ARWR — Arrowhead Pharmaceuticals, Inc. (ARWR)
Every disclosed congressional transaction in this security, both parties, every chamber. Each row links to the filing it came from.
These are legally required disclosures, not allegations — timing can be coincidence.
Who trades it, and which way
By party
Democrats 1 Republicans 0
By direction
Purchases 0 Sales 1
Inside its sector Pharmaceuticals & Biotech
Congressional transactions per security in this sector — the page you are on is highlighted.
Plus 1,070 transactions across the sector's other securities.
Follow the federal money
Why a company's stock can be sensitive to what Congress does: many of them are also paid by the government. Arrowhead Pharmaceuticals, Inc.'s federal contracts, grants and loans are public record.
Look up Arrowhead Pharmaceuticals, Inc. on USASpending →
We link to the source rather than repeat a dollar figure here. Federal awards are recorded under many recipient names — a parent company and its subsidiaries — so an accurate company-wide total has to be read at USASpending itself, where the recipient hierarchy is resolved. Present this beside the trading record and draw your own conclusions.
Transactions
| Date | Member | Action | Amount (as filed) | Owner | Filing |
|---|---|---|---|---|---|
| 2023-01-31 | Daniel S. Goldman D-NY | sell | $1,001 – $15,000 | self | record |
Prices are market data (split- and dividend-adjusted closes), used only for context — every disclosure fact on this page comes from the filings linked in the table above. See Methodology.